Literature DB >> 1431963

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

P Scheltens1, D Leys, F Barkhof, D Huglo, H C Weinstein, P Vermersch, M Kuiper, M Steinling, E C Wolters, J Valk.   

Abstract

Magnetic resonance imaging (MRI) has shown a great reduction in medial temporal lobe and hippocampal volume of patients with Alzheimer's disease as compared to controls. Quantitative volumetric measurements are not yet available for routine clinical use. We investigated whether visual assessment of medial temporal lobe atrophy (MTA) on plain MRI films could distinguish patients with Alzheimer's disease (n = 21) from age matched controls (n = 21). The degree of MTA was ascertained with a ranking procedure and validated by linear measurements of the medial temporal lobe including the hippocampal formation and surrounding spaces occupied by cerebrospinal fluid. Patients with Alzheimer's disease showed a significantly higher degree of subjectively assessed MTA than controls (p = 0.0005). Linear measurements correlated highly with subjective assessment of MTA and also showed significant differences between groups. Ventricular indices did not differ significantly between groups. In Alzheimer's disease patients the degree of MTA correlated significantly with scores on the mini-mental state examination and memory tests, but poorly with mental speed tests. This study shows that MTA may be assessed quickly and easily with plain MRI films. MTA shown on MRI strongly supports the clinical diagnosis of Alzheimer's disease, is related to memory function, and seems to occur earlier in the disease process than does generalised brain atrophy.

Entities:  

Mesh:

Year:  1992        PMID: 1431963      PMCID: PMC1015202          DOI: 10.1136/jnnp.55.10.967

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Verbal memory impairment correlates with hippocampal pyramidal cell density.

Authors:  K J Sass; D D Spencer; J H Kim; M Westerveld; R A Novelly; T Lencz
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

3.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

4.  Loss of recent memory after bilateral hippocampal lesions.

Authors:  W B SCOVILLE; B MILNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

5.  Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging.

Authors:  D Leys; G Soetaert; H Petit; A Fauquette; J P Pruvo; M Steinling
Journal:  Arch Neurol       Date:  1990-05

6.  [Alzheimer's disease. Statistical analysis of CT scanner data].

Authors:  D Leys; J P Pruvo; H Petit; Y Gaudet; J Clarisse
Journal:  Rev Neurol (Paris)       Date:  1989       Impact factor: 2.607

7.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

Authors:  M C Tierney; R H Fisher; A J Lewis; M L Zorzitto; W G Snow; D W Reid; P Nieuwstraten
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

8.  Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome.

Authors:  H A Crystal; D S Horoupian; R Katzman; S Jotkowitz
Journal:  Ann Neurol       Date:  1982-08       Impact factor: 10.422

9.  Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage.

Authors:  A R Damasio; P J Eslinger; H Damasio; G W Van Hoesen; S Cornell
Journal:  Arch Neurol       Date:  1985-03

10.  Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging.

Authors:  G A Press; D G Amaral; L R Squire
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

View more
  419 in total

1.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

Review 3.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

4.  Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.

Authors:  Marina Boccardi; Rossana Ganzola; Martina Bocchetta; Michela Pievani; Alberto Redolfi; George Bartzokis; Richard Camicioli; John G Csernansky; Mony J de Leon; Leyla deToledo-Morrell; Ronald J Killiany; Stéphane Lehéricy; Johannes Pantel; Jens C Pruessner; H Soininen; Craig Watson; Simon Duchesne; Clifford R Jack; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

6.  Morphologic and neuropsychological patterns in patients suffering from Alzheimer's disease.

Authors:  Pierre Chapuis; Mathilde Sauvée; Maud Medici; Amélie Serra; Eldda Banciu; Alexandre Moreau-Gaudry; Olivier Moreaud; Alexandre Krainik
Journal:  Neuroradiology       Date:  2016-02-15       Impact factor: 2.804

7.  Feasibility and acceptance of simultaneous amyloid PET/MRI.

Authors:  Lisa Schütz; Donald Lobsien; Dominik Fritzsch; Solveig Tiepolt; Peter Werner; Matthias L Schroeter; Jörg Berrouschot; Dorothee Saur; Swen Hesse; Thies Jochimsen; Michael Rullmann; Bernhard Sattler; Marianne Patt; Hermann-Josef Gertz; Arno Villringer; Joseph Claßen; Karl-Titus Hoffmann; Osama Sabri; Henryk Barthel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-19       Impact factor: 9.236

8.  Evaluation of Ultrafast Wave-CAIPI MPRAGE for Visual Grading and Automated Measurement of Brain Tissue Volume.

Authors:  M G F Longo; J Conklin; S F Cauley; K Setsompop; Q Tian; D Polak; M Polackal; D Splitthoff; W Liu; R G González; P W Schaefer; J E Kirsch; O Rapalino; S Y Huang
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

9.  Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure.

Authors:  Alan Pan; Rajesh Kumar; Paul M Macey; Gregg C Fonarow; Ronald M Harper; Mary A Woo
Journal:  J Card Fail       Date:  2013-02       Impact factor: 5.712

10.  Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.

Authors:  Ana Verdelho; Sofia Madureira; José M Ferro; Anna-Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.